Stockreport

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies [Y...

Geron Corporation  (GERN) 
Last geron corporation earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: geron.com/investors
PDF RYTELO (imetelstat) can cause thrombocytopenia, neutropenia, infusion-related reactions, and embryo-fetal harm when administered to a pregnant woman. The analysis sho [Read more]